|
| | Betamethasone EP Impurity J Basic information |
| Product Name: | Betamethasone EP Impurity J | | Synonyms: | Betamethasone EP Impurity J;Betamethasone Impurity 10（Betamethasone EP Impurity J）;(8R,9S,10R,13S,14S,16S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one;16β-Methyl-17α-Dihydroxypregna-1,4-diene-3,20-dione;17,21-Dihydroxy-16b-methylpregna-1,4-diene-3,20-dione;16β-Methyl-17α,21-Dihydroxypregna-1,4-diene-3,20-dione;9-Desfluoro-11-deoxy Betamethasone;Pregna-1,4-diene-3,20-dione, 17,21-dihydroxy-16-methyl-, (16β)- | | CAS: | 18383-24-9 | | MF: | C22H30O4 | | MW: | 358.47 | | EINECS: | | | Product Categories: | | | Mol File: | 18383-24-9.mol |  |
| | Betamethasone EP Impurity J Chemical Properties |
| Boiling point | 530.9±50.0 °C(Predicted) | | density | 1.22±0.1 g/cm3(Predicted) | | pka | 12.65±0.70(Predicted) |
| | Betamethasone EP Impurity J Usage And Synthesis |
| Uses | 16β-Methyl-17α-Dihydroxypregna-1,4-diene-3,20-dione is an intermediate in the synthesis of 17,21-dihydroxy-16β-methylpregna-1,4-diene-3,20-dione (D434280), a corticoid with the potential for ant-iinflammatory activity. |
| | Betamethasone EP Impurity J Preparation Products And Raw materials |
|
